Unlike angiotensin IV, which cannot effectively penetrate brain tissue, Dihexa possesses the unique ability to cross the blood-brain barrier when administered orally, making it a viable candidate for therapeutic applications in neurodegenerative conditions
They are used in patients with cardiovascular risk and/or suffering with cardiovascular disease
Moreover, there might be modulatory effects on the prostaglandins system [2,3,4,5,6,7,8,74]
Patients interested in enhancing their overall appearance alongside their metabolic care can explore options such as non-invasive neck and jawline contouring, PDO thread lifts, Botox, or FaceTite under the care of the Formation team
In animal models, KD feeding reduced the expression of pro-apoptotic mediators such as clusterin, caspase-3, and Bax, while upregulating the anti-apoptotic protein Bcl-2 [47, 48]